BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10068736)

  • 21. Combined adenocarcinoma and carcinoid tumor in atrophic gastritis.
    Adhikari D; Conte C; Eskreis D; Urmacher C; Ellen K
    Ann Clin Lab Sci; 2002; 32(4):422-7. PubMed ID: 12458898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuroendocrine gastric carcinoma. A case report and review of current management].
    Mondragón-Sánchez A; Mondragón-Sánchez R; Bernal Maldonado R; Baquera-Heredia J; Gómez-Gómez E
    Rev Gastroenterol Mex; 2003; 68(2):129-32. PubMed ID: 15127650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do neuroendocrine cells, particularly the D-cell, play a role in the development of gastric stump cancer?
    Waldum HL; Haugen OA; Brenna E
    Cancer Detect Prev; 1994; 18(6):431-6. PubMed ID: 7867015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric carcinoids of ECL cells. Pathological and clinical analysis of eight cases.
    Grigioni WF; Caletti GC; Gabrielli M; Marrano D; Villanacci V; Mancini A
    Acta Pathol Jpn; 1985 Mar; 35(2):361-75. PubMed ID: 4024941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs.
    Campana D; Nori F; Pezzilli R; Piscitelli L; Santini D; Brocchi E; Corinaldesi R; Tomassetti P
    Endocr Relat Cancer; 2008 Mar; 15(1):337-42. PubMed ID: 18310299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric carcinoids in patients with hypergastrinemia.
    Jordan PH; Barroso A; Sweeney J
    J Am Coll Surg; 2004 Oct; 199(4):552-5. PubMed ID: 15454137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clear cell carcinoid tumor of stomach. A variant mimicking gastric xanthelasma.
    Luk IS; Bhuta S; Lewin KJ
    Arch Pathol Lab Med; 1997 Oct; 121(10):1100-3. PubMed ID: 9341592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A gastric multiple neuroendocrine tumor. A case report].
    Giles DM; Bordenave CA
    Acta Gastroenterol Latinoam; 1992; 22(3):191-5. PubMed ID: 1341119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mixed exocrine-endocrine gastric carcinoma: a rarity of little consequence?].
    Sauer J; Hinze R; Dommisch K
    Dtsch Med Wochenschr; 2007 Oct; 132(40):2077-80. PubMed ID: 17899502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
    Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
    Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report.
    Eckhauser FE; Lloyd RV; Thompson NW; Raper SE; Vinik AI
    Surgery; 1988 Dec; 104(6):1046-53. PubMed ID: 3194832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of ECL cell tumors.
    Cadiot G; Cattan D; Mignon M
    Yale J Biol Med; 1998; 71(3-4):311-23. PubMed ID: 10461362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrine differentiation in human gastric carcinoma.
    Waldum HL; Aase S; Kvetnoi I; Brenna E; Sandvik AK; Syversen U; Johnsen G; Vatten L; Polak JM
    Cancer; 1998 Aug; 83(3):435-44. PubMed ID: 9690535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and treatment of gastric carcinoid tumors].
    Sang X; Gao W; Tang W
    Zhonghua Wai Ke Za Zhi; 1999 Mar; 37(3):151-3. PubMed ID: 11829806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia.
    Sjöblom SM; Sipponen P; Miettinen M; Karonen SL; Jrvinen HJ
    Endoscopy; 1988 Mar; 20(2):52-6. PubMed ID: 3383791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodality treatment for gastric carcinoid tumor with liver metastases.
    Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
    Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fundic endocrine tumors and atrophic gastritis: the value of antrectomy].
    Guillem P; Vlaeminck-Guillem V; Leteurtre E; Kornhauser R; Cortot A; Wemeau JL; Triboulet JP
    Gastroenterol Clin Biol; 2002; 26(8-9):782-5. PubMed ID: 12434081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multifocal gastric carcinoid associated with chronic type A atrophic gastritis. Analysis of 2 clinical cases].
    Moneghini D; Fontana MG; Villanacci V; Salerni B
    Ann Ital Chir; 2001; 72(1):89-92; discussion 92-3. PubMed ID: 11464502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.